Skip to main content
OpenTrials
Completed

NCT Number: NCT03125850

Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients

This study will compare the glaucoma day-ward patients' efficacy with inpatients by evaluating the glaucoma knowledge and psychology , and will analysis the reasons of the differences. Half of participants will receive treatment in day-ward, while the other half will receive treatment in hospital.

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Zhongshan Ophthalmic Center, Sun Yat-San Univerdity

Guangzhou, Guangdong, China

About this study

Ophthalmic surgery has short operative time, quick recovery, and small anesthesia risk, making day case surgery the main management mode of ophthalmic surgery. This study will explore the differences of psychology and glaucoma knowledge between glaucoma day-ward patients and the inpatients. The data will be collected by scale on admission and discharge.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is diagnosed with glaucoma;
  • Will receive glaucoma surgery;
  • Voluntary participation in this study;
  • Have enough language comprehension ability;
  • Best corrected visual acuity reach 0.1 or better;
  • Patient or his legal representative has sign the informed consent.

Exclusion criteria

  • Patient with mental disorder;
  • There are important viscera function failure or other serious disease, including clinical related coronary artery disease, cardiovascular disease or myocardial infarction into the group of the first six months; serious neurological or psychiatric illness; serious infections; coagulant function abnormality; general active infectious diseases; malignant tumor; serious immune diseases;
  • Patient with monocular blindness;
  • Axial length≤20 mm;
  • With other serious eye diseases;
  • Neurologic diseases that could affect the visual field;
  • 3 months prior to research to participate in any clinical study;
  • Researchers think not suitable to participate in this clinical trial subjects;
  • Refused to sign the informed consent.

Treatment and study plan

randomized to day ward

Other

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

randomized to inpaitent

Other

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

Primary outcomes

  1. Change of depression and anxiety score

    Time frame: at baseline and 1 hour before discharge

    The outcome will be measured by The Hospital Depression and Anxiety Scale (HADS). It consists of two subscales: HDAS-anxiety and HADS-depression. Each item is srored from 0-3, with higher scores indicating a higher level of depression and anxiety. For each of the seven-item subscales, the minimum sum score is 0, and the maximum is 21.

  2. Change of glaucoma knowledge score

    Time frame: at baseline and 1 hour before discharge

    The outcome will be measured by The Gray Glaucoma Knowledge Questionaire. This quesionanire has a total maximum score of 17, with higher scores representing better knowledge.

Sponsors and collaborators

Lead sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Other

Registry information

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
Apr 24, 2017
Registry last updated
Jul 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.